Previous Article | Next Article ![]()
Journal of Bacteriology, July 2006, p. 5089-5100, Vol. 188, No. 14
0021-9193/06/$08.00+0 doi:10.1128/JB.01929-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Doris R. Majerczak,1
Michael Zianni,2
Kimberly Tessanne,2 and
David L. Coplin1*
Department of Plant Pathology and the Plant Molecular Biology and Biotechnology Program,1 Plant-Microbe Genomic Facility, The Ohio State University, Columbus, Ohio 432102
Received 16 December 2005/ Accepted 27 April 2006
|
|
|---|
70 promoter 601 bp upstream of the open reading frame. Electrophoretic mobility shift assays and DNase I footprinting analysis demonstrated that HrpY binds to conserved regulatory elements immediately adjacent to this promoter, and its binding affinity was increased by phosphorylation at D57. A consensus sequence for the two direct repeats bound by HrpY is proposed. Deletion analysis of the promoter region revealed that both the HrpY binding site and additional sequences farther upstream, including a putative integration host factor binding site, are required for hrpS expression. This finding suggests that other unknown regulatory proteins may act cooperatively with HrpY. |
|
|---|
HrpY has sequence similarity to the FixJ class of response regulators (25), which includes Escherichia coli NarL and UhpA and Bacillus subtilis DegU. Members of this class share a typical modular organization (31), with a conserved N-terminal receiver domain, a flexible linker, and a C-terminal domain that contains a LuxR/GerR superfamily DNA-binding motif. The N-terminal receiver domain of P. stewartii HrpY contains three conserved aspartyl residues (D11, D12, and D57). By homology to other response regulators and protein modeling (22), D57 is expected to be the phosphorylation site. In agreement with this prediction, conservative and structurally neutral amino acid substitutions at this position, such as D57N and D57A, abolish virulence when the hrpY allele is expressed in single copy from the chromosome (25). Interestingly, the same mutant proteins are functional when expressed from a low-copy-number plasmid. Using a genetic approach, we previously showed that P. stewartii HrpY activates expression of hrpS and autoregulates the hrpXY operon (25). Moreover, the hrpS promoter (PhrpS) region appears to be a key control point for the integration of various signaling pathways that modulate spatiotemporal hrp gene expression in response to metabolic status, pH, and osmotic pressure (22). In addition, HrpS initiates a novel autoregulatory loop caused by readthrough transcription from hrpL into hrpXY (24). In contrast, the hrpXY operon is constitutively expressed at a moderate level and appears to be involved in transducing only a few of these signals (23). Although HrpX is required for full hrp gene expression in inducing medium, hrpX mutants are still quite virulent on corn, in contrast to hrpY mutants that are totally nonpathogenic. This suggests that cross talk among related sensor kinases or acetyl phosphate occurs in planta. Together, these findings open the possibility that other regulatory factors also modulate hrpS transcription, either by direct regulation of PhrpS or via phosphorylation of HrpY. It is interesting that each phytopathogenic bacterium appears to respond somewhat differently to external signals and growth conditions (19, 25, 27, 35, 36, 39), so that regulation of hrpS by specific and global regulators may be fine-tuned for each pathogen's niche. For this reason, it is important to understand how various regulatory molecules, especially HrpY, interact with PhrpS. At this point, a direct, physical interaction between HrpY and hrpS regulatory sequences has not been demonstrated in any species.
In this study, we show that only some of the multiple signals controlling the hrpS promoter are mediated by HrpY. We characterized the hrpS promoter by locating its transcription start site, identifying the region required for HrpY-dependent regulation, and determining the sequences to which HrpY binds. We also showed that HrpY has a single phosphorylation site and that phosphorylation increases its binding affinity to PhrpS. Our results further suggest that other unidentified regulatory factors may act in concert with HrpY to control hrpS expression.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. Bacterial strains and plasmids
|
. The recombinant plasmids were screened by DNA sequencing to identify deletion mutants. The resulting plasmids pMM1100, pMM1101, pMM1102, pMM1103, pMM1001, and pMM1002 were digested with BamHI, and the inserts were subcloned into pPL6GUS to produce plasmids pDM2958, pDM2960, pDM2963, pDM2965, pDM2949, and pDM2953, respectively. Plasmids pMM74 and pMM118, carrying the hrpY D57A and D57N alleles, were generated by subcloning hrpY from plasmids pMM57 and pMM92 into pRK415 for expression from Plac. Construction of hrpY plasmids for protein expression and purification. hrpY was amplified by PCR using Pfu DNA polymerase (Clontech), primers ET-YF-NdeI and ET-YR-NdeI (see Table S1 in the supplemental material) and plasmids pMM46 hrpY+ or pMM92 hrpY(D57N) as DNA templates (25). Primer ET-YF-NdeI introduced an NdeI site at the start codon of hrpY and maintained the reading frame with the vector's N-terminal His6 tag; primer ET-YR-NdeI introduced three stop codons downstream of the hrpY open reading frame (ORF). The 670-bp PCR fragments, spanning either hrpY+ or hrpY(D57N), were gel purified, digested with NdeI, and ligated into an NdeI-linearized pET-15b vector (Novagen). The resulting plasmids, pMM221 and pMM222, carried hrpY and hrpY(D57N), respectively, fused to an N-terminal His6 tag and expressed from a T7lac IPTG (isopropyl-ß-D-thiogalactopyranoside)-inducible promoter. The inserts in plasmids pMM221 and pMM222 were sequenced to confirm that they did not contain PCR errors.
Purification of His6-HrpY proteins. Plasmids pMM221 and pMM222 were transformed by electroporation into E. coli BL21(DE3) carrying pLysS. For protein expression, bacteria were grown in 1 liter of LB broth until the culture reached an A600 of 0.8. IPTG was added to a final concentration of 1 mM, and the culture was grown at 15°C for 18 h until an A600 reached 1.4. Cells were harvested by centrifugation and resuspended in 35 ml of ice-cold lysis buffer (10 mM imidazole, 500 mM NaCl, 1 mM MgCl2, 1 mM phenylmethylsulfonyl fluoride [PMSF], 20 mM Tris-HCl, pH 7.9 at 4°C), containing 50 µl of protease inhibitor cocktail (Sigma). The cell suspension was incubated in 0.1 mg ml1 lysozyme for 20 min on ice and then passed two times through a 40-K French pressure cell (Thermo-IEC) at 10,000 lb/in2. The lysate was centrifuged twice at 20,000 x g for 30 min at 4°C. Column chromatography was performed at 4°C. The supernatant was then applied to a 1.5-ml Ni2+-iminodiacetic acid column packed using His-Bind resin (Novagen), prepared according to the manufacturer's instructions. The column was washed with 10 column volumes of lysis buffer and 10 column volumes of washing buffer (40 mM imidazole, 500 mM NaCl, 1 mM MgCl2, 0.5 mM PMSF, 20 mM Tris-HCl, pH 7.9 at 4°C). The target His6-HrpY proteins were eluted with a step gradient of 100 mM and 250 mM imidazole buffers (100 mM or 250 mM imidazole, 500 mM NaCl, 20 mM Tris-HCl, pH 7.9 at 4°C, 1 mM MgCl2, 0.5 mM PMSF). Fractions containing higher concentrations of the 26.1-kDa recombinant protein, as assayed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), were pooled and dialyzed overnight against storage buffer (67 mM potassium glutamate, 125 mM HEPES, pH 7.9 at 4°C, 0.5 mM dithiothreitol [DTT], 0.5 mM PMSF, 20% glycerol). The protein was further purified by anion exchange chromatography in a Q-Sepharose (Amersham-Pharmacia) column after dialysis against buffer A (20 mM Tris-HCl, pH 8.0 at 4°C, 25 mM NaCl, 0.25 mM EDTA, 0.2 mM PMSF) prepared according to the manufacturer's instructions. Proteins were eluted in a linear buffer gradient prepared by mixing buffer A with buffer B (20 mM Tris-HCl, pH 8.0 at 4°C, 500 mM NaCl, 0.25 mM EDTA, 0.2 mM PMSF). Fractions containing highly purified His6-HrpY were pooled, and the buffer was exchanged for 1x storage buffer (10 mM Tris-HCl, pH 7.9, 125 mM NaCl, 1 mM DTT, 3 mM MgCl2, 38% glycerol) by repeated centrifugation, according to the manufacturer's instructions, in a Vivaspin 15R ultrafiltration tube (Viva Science) with a molecular mass cutoff of 10 kDa or by Sephadex G25-HiTrap Desalt chromatography (Amersham). Protein concentration was determined by the dye-binding method of Bradford (6). The degree of purification was estimated by Coomassie brilliant blue staining after SDS-PAGE (18).
MS. Protein molecular mass measurements were performed at the Ohio State University Campus Chemical Instrument Center-Mass Spectrometry Facility by electrospray ionization (ESI) mass spectrometry (MS) using a Micromass Q-TOF II (quadrupole-time of flight) mass spectrometer equipped with an orthogonal nanospray source (Z-spray) operated in positive ion mode. Tandem MS of [Glu]-fibrinopeptide B was used for mass calibration in a calibration range of m/z 100 to 2,000. Salt buffers from the protein samples were cleaned using manual syringe protein traps from Michrom BioResources. Desalted protein samples were prepared in a solution containing 50% acetonitrile-0.1% formic acid and infused into the nanospray source at a rate of 0.5 to 1.0 ml min1. Optimal conditions were a capillary voltage of 3,000 V, a source temperature of 110°C, and a cone voltage of 60 V. Quadrupole 1 was set to optimally pass ions from m/z 100 to 2,000, and all ions transmitted into the pusher region of the TOF analyzer were scanned over the m/z range with a 1-s integration time. Data were acquired in the continuum mode until acceptable averaged data were obtained (10 to 15 min). ESI data were deconvoluted using MaxEnt I (Micromass).
In vitro phosphorylation of HrpY.
For enzymatic phosphorylation, 15 µl of a mixture containing 25 µM His6-HrpY, 75 µM Salmonella enterica BarA198 (obtained from M. Teplitski) (32), 40 µM [
32-P]ATP (10 Ci/mmol; NEN) and 0.1 mM cold ATP in phosphorylation buffer was incubated at 25°C for 90 min. Reactions were terminated with 5 µl of 4x stop buffer (125 mM Tris-HCl, pH 6.8, 8 mM EDTA, 4% SDS, 8% ß-mercaptoethanol, 20% glycerol, 0.02% bromophenol blue), separated by SDS-PAGE (12% monomer gel), and visualized by Coomassie brilliant blue staining (18). Gels were dried under vacuum at 60°C for 30 min. The radiolabeled proteins were visualized with a storage phosphor screen, analyzed on a Molecular Dynamics Storm-840 PhosphorImager, and quantified with ImageQuant.
EMSA.
DNA fragments used as probes for electrophoretic mobility shift assays (EMSA) were made by PCR using plasmid pMM58, which carries the hrpL, hrpXY, and hrpS genes (25), as a template. Six probes (A, B, C, C1, C2, and C3) were designed to amplify various fragments of the hrpS regulatory region located upstream of the IS-like element. Primers SF3509 and SR3845 were used for amplification of fragment A (327 bp), SF3509 and SR3575 for fragment B (76 bp), SF3575 and SR3645 for fragment C (261 bp), SF3575 and SR3650 for fragment C1 (76 bp), SF3650 and SR3689 for fragment C2 (86 bp), and SF3689 and SR3845 for fragment C3 (101 bp). PCR products were purified from agarose or acrylamide gels and quantified by the ethidium bromide staining spot method (4). DNA fragments were labeled at the 5' ends by incubation with T4 polynucleotide kinase (USB) and [
-32P]ATP (3,000 Ci/mmol; NEN). Unincorporated nucleotides were removed by Sephadex G-25 spin chromatography (4), and labeled DNA was diluted to 10,000 cpm µl1 (Cerenkov counts). DNA binding reactions (20 µl) contained 15 to 50 fmol of 32P-labeled DNA probe, various amounts of His6-HrpY, 200 ng of acetylated bovine serum albumin (NEB), and 1 µg of poly(dI-dC) (Roche) in binding buffer (125 mM potassium glutamate, 125 mM HEPES, pH 7.9, 75 mM NaCl, 5 mM MgCl2, 0.1 mM EDTA, 0.2 mM DTT). Unlabeled specific competitor DNA was added before the addition of His6-HrpY. The reactions were incubated at 25°C for 30 to 40 min. Reaction mixtures were loaded, without loading buffer, onto 6% acrylamide nondenaturing gels in a vertical gel apparatus (model V16; Waterman), run at 200 V for 2.0 to 2.5 h. Gel and running buffers were 1x TBE (97 mM Tris-HCl, 90 mM borate, 3 mM EDTA, pH 8.0). The gels were dried under vacuum at 80°C, and the radioactive fragments were visualized either by autoradiography at 80°C with Kodak MS films or by using a storage phosphorimager for quantification.
DNase I footprinting. DNase I footprinting to map the physical contacts between HrpY and the hrpS promoter region was performed using fluorescently labeled DNA and an automated sequencer to resolve the digestion products, as described by Zianni et al. (40). Primers SF3509 and SR3845, which delimit hrpS fragment C, were synthesized as 6-carboxyfluorescein (6-FAM) 5'-labeled oligonucleotides by Integrated DNA Technologies. Fragment C was amplified as a singly end-labeled PCR product using plasmid pMM58 as a template. PCR products were purified by gel electrophoresis and quantified by UV spectrophotometry. The labeled probes (45 ng) were incubated with amounts of His6-HrpY protein ranging from 0 to 40 µM in binding buffer (150 mM KCl, 5 mM MgCl2, 0.1 mM EDTA, 1 mM DTT, 8% glycerol in 10 mM Tris-HCl, pH 8.0). Nuclease digestion was performed with 0.0025 Kunitz units of DNase I (Worthington Biochemicals) per 20-µl reaction mixture for 5 min. The reaction was stopped by the addition of 0.25 M EDTA and extracted with phenol-chloroform-isoamyl alcohol (25:24:1). The DNA fragments were purified in a QIAGEN spin column. Sequencing reactions were performed using a Thermo Sequenase Dye Primer Manual Cycle sequencing kit from USB according to the manufacturer's instructions. Reactions contained 200 ng of pMM58 plasmid DNA template and 20 pmol of 6-FAM-labeled SF3509 primer. Cycling conditions consisted of a 30-s denaturation at 95°C, 30-s annealing step at 50°C, and 60-s extension at 72°C, for a total of 60 cycles. A 0.1-µl aliquot of Genescan-500 LIZ size standard (Applied Biosystems) was combined with either 1 µl of sequencing product or 5 µl of DNase I digestion products in a 10-µl final volume. Samples were loaded onto a 3730 DNA analyzer (Applied Biosystems) for electrophoresis and detection. Electropherograms were aligned using GeneMapper 3.5 (Applied Biosystems).
GUS enzyme assays. GUS activity was assayed fluorometrically using 4-methyl-umbelliferyl-ß-D-glucuronide as described by Jefferson (15), but the assays were scaled down to fit microtiter plates and analyzed using a Victor 1420-2 multilabel reader (PE Applied Biosystems). Net GUS activity of each strain was corrected for the basal fluorescence of P. stewartii DC283 carrying pPL6GUSC without an insert. Specific activity was expressed in GUS units (1 unit is defined as 1 pmol of 4-methyl-umbelliferone min1 per unit of optical density at 600 nm ml1 of culture at 37°C).
Primer extension, DNA sequencing, and bioinformatics. DNA-free total RNA was isolated from 25 ml of overnight cultures of bacteria grown in IM5.5 liquid medium using an RNA Wizard prep kit (Promega) as per the manufacturer's instructions. RNA was precipitated by adding two volumes of isopropanol, and the precipitate was washed in 70% ethanol. The RNA pellet was resuspended in 50 µl of diethypyrocarbonate-treated water and treated with DNase I (Invitrogen) according to the manufacturer's instructions. Analysis of the 5' ends of the hrpS mRNA transcripts was performed by primer extension using 6-FAM-labeled primers. A total of 100 pmol of primer 6-FAM-SR3735 was annealed to 50 µg of RNA purified by using a Wizard Total RNA kit (Promega). Synthesis of cDNA was performed using SuperScript II reverse transcriptase (Invitrogen) according to the manufacturer's instructions. DNA sequencing was performed with the same primers used for cDNA synthesis by following the procedure used for DNA footprinting. Denatured single-stranded DNAs were analyzed in an ABI 3770 capillary electrophoresis sequencer. DNA bending ability was predicted using Bend-It (26). Promoter and DNA binding site predictions were determined with BPROM (http://www.softberry.com/), PromScan (http://molbiol-tools.ca/mtoolwww-cgi/promscan.cgi), and SEQSCAN (http://www.bmb.psu.edu/seqscan/).
Nucleotide sequence accession number. The updated sequence of the P. stewartii hrp cluster has been deposited in the GenBank database under accession number AF282857.
|
|
|---|
![]() View larger version (30K): [in a new window] |
FIG. 1. The effect of environmental stimuli on hrpS-lacZ expression and suppression of these effects by ectopic overexpression of hrpY(D57N). The P. stewartii strain MEX1 hrpS-lacZ and its derivative DM733 hrpY::Tn5 hrpS-lacZ carrying pMM118 Plac-hrpY(D57N) were grown to an A600 nm of 0.6 to 0.8. Expression of hrpS-lacZ was measured using a fluorometric ß-galactosidase assay, and the data are shown as a percentage of the respective vector control strain grown in IM5.5. Media are as follows: IM5.5, standard IM lacking casamino acids with 10 mM sucrose as the C-source; High NaCl, IM5.5 with 250 mM NaCl; pH 8.0, IM buffered with HEPES to pH 8.0; nicotinic acid, IM5.5 with 2 mM nicotinic acid; citrate, IM5.5 with 10 mM trisodium citrate as a sole C source; tryptone, IM5.5 with 0.125% tryptone as the sole source of C and N. Error bars indicate standard deviations. Data are from a representative experiment with three replicates.
|
G° of 149.2 kcal/mol). At present, the regulatory significance of this feature is unknown, and it will not be addressed in this study.
Primer extension was used to determine the 5' end of the hrpS mRNA transcript. Given the large size of the 5' hrpS region, we used five primers spanning the entire hrpS 5' region (see Table S1 in the supplemental material). Only one of the primers resulted in a clear extension product. Using the 6-FAM-labeled SR3835 primer under Hrp-inducing growth conditions, the hrpS mRNA starting site was located at the cytosine base 602 bp upstream of the hrpS start codon (Fig. 2). A putative
70 promoter (TTATCT-N17-TCTTAT) centered at 29 bp from the transcription start (see Fig. S1 in the supplemental material) was identified using PromScan (score, 70). The DNA sequences of the hrpS 5' regions from E. amylovora, P. stewartii, P. agglomerans pv. gypsophilae, E. carotovora subsp. carotovora, E. carotovora subsp. atroseptica, and E. chrysanthemi were aligned by ClustalW (not shown) in order to identify common motifs. Given that these species exhibit similar HrpY-dependent regulation of the hrpS gene and that the 5' regions are very similar, we predicted that common regulatory elements might be present. The regions chosen for analysis included nucleotides +1 to 241 from the transcriptional start in P. stewartii and the corresponding sequences in the hrpY-hrpS intergenic regions of various erwinia group species starting from the 3' UTR of hrpY. (P. stewartii is the only species that has an IS-like element upstream of hrpS). The P. stewartii hrpS 5' region appears to be most closely related to that of P. agglomerans pv. gypsophilae, with E. amylovora being the second most similar species. The pectolytic Erwinia spp. grouped separately at higher genetic distances upon phylogenetic analysis (not shown). The P. stewartii and P. agglomerans pv. gypsophilae 5' hrpS gene sequences exhibited 69.8% identity to each other over the entire 232 bp, whereas P. stewartii and E. carotovora subsp. atroseptica had only 39.6% identity. Two short direct repeats (DRs) were centered at 74 and 95 (AAATCCTTAC-N11-AATTCCTTAC) (Fig. S1). These were present in all the erwinias, but were most conserved in the pantoeas. A potential integration host factor (IHF) binding site at 191 to 179 (TTTCAACAGGTTA; consensus, WATCAA-N4-TTR; score, 74) was identified using PromScan with the E. coli K12 consensus matrix (Fig. S1). IHF belongs to a class of DNA bending proteins that are able to impose strong curvatures in A+T-rich DNA (30). IHF binding sites are associated with many different kinds of promoters and are usually located between 60 and 150 bp upstream, which is fairly close to the location of the site found by PromScan. The curvature propensity and bending ability of the P. stewartii hrpS promoter region was therefore analyzed using the Bend-It algorithm. A high propensity for bending (>6° per helical turn) was predicted between 170 and 70 bp, with two peaks of intrinsic curvature located around positions 139 and 157 bp.
![]() View larger version (20K): [in a new window] |
FIG. 2. Primer extension analysis of the hrpS promoter. Total RNA from DC283 cells grown in IM5.5 was annealed with 6-FAM-labeled primer SR3745 complementary to the 5' UTR of hrpS and extended as described in Material and Methods. Dideoxy sequencing ladders were generated for the hrpS 5' UTR with the same primer and pMM56 DNA as a template. Reactions were appropriately diluted and run in a capillary electrophoresis sequencer to correctly estimate the size and position of the 6-FAM-labeled primer extension product (asterisk). The signal from each chromatographic peak is reported as relative fluorescence units. The bases corresponding to the transcription start on the coding strand are indicated, with the transcription start (+1) shown in a larger font. Map coordinates are relative to the transcription start site.
|
70 promoter (Fig. 3).
![]() View larger version (29K): [in a new window] |
FIG. 3. Deletion analysis of the hrpS regulatory region. The various hrpS promoter fragments carrying deletions from the 5' end or internal deletions were cloned into plasmid pPL6GUSC to create PhrpS-uidA (gusA) transcriptional gene fusions. All fusions included the 493-bp IS element remnant in the 5' UTR and a portion of the hrpS ORF. GUS activity was determined for each plasmid in wild-type strain DC283 (296 ± 5 GUS units), the hrpY::Tn5 mutant DM064, and the hrpY(D57N) mutant MM254 after growth in IM5.5 for 16 h. Data are expressed as percent activity compared to the wild-type control fusion in DC283. Data are from a representative experiment with four independent replicates per strain. GUS activities are reported as pmol of 4-methyl-umbelliferone min1 per unit of optical density at 600 nm ± standard deviation. The coordinates shown above the genetic map are relative to the hrpS transcriptional start site. The 70 promoter is indicated. RBS indicates the ribosomal binding site; DR12 is the region spanned by the two DRs described in the legend of Fig. 2; and 5a, 5b, and 10 are deletions of 5 bp, 5 bp, and 10 bp, respectively.
|
DR12, 121 to 70 in pDM2912). This resulted in a strong reduction in PhrpS-uidA expression in both genetic backgrounds to levels about 8% that of the pMM400 control fusion (Fig. 3). We then made a smaller deletion (
DR12, 99 to 69 in pDM2932) that included only the two DR sites and the 11 bp separating them (approximately one DNA helix turn), and this construct exhibited the same very low level of expression. To estimate the relative contribution of individual repeats, we then individually deleted each DR. The resulting fusions (
DR1, 99 to 90 in pDM2949, and
DR2, 78 to 69 in pDM2958) showed twice as much activity as the
DR12 fusions, but their expression was still only 22 to 26% of the pMM400 control (Fig. 3). This result suggests that these two repeats contribute in a cooperative way to the expression of hrpS. The above findings are consistent with a model whereby both sequences next to the hrpS promoter and other elements much farther upstream are required for full activation of PhrpS. The strong reduction in expression observed upon deletion of the putative IHF site also suggests the involvement of DNA bending, which might bring an unknown coactivator, binding near the IHF site, into contact with HrpY. This model predicts that small progressive deletions, changing the phase of the DNA helix, will lead to incorrect topology of the binding elements for regulatory factors. To test this hypothesis, we separately created two different 5-bp deletions in the region halfway between the IHF element and the DR region (144 to 140 in pDM2960 and 139 to 135 in pDM2963). Each deletion was expected to shift the phase of the helix by half a turn. Both mutations had a large negative effect on PhrpS expression (Fig. 3). In contrast, an in-phase 10-bp deletion spanning both sites (144 to 135 in pDM2965) did not decrease PhrpS expression but, instead, seemed to stimulate it above wild-type levels (Fig. 3). These findings are consistent with the existence of factors that require a correct DNA topology to bind to upstream elements and activate the hrpS promoter.
Purification of recombinant HrpY.
To begin addressing questions concerning the biochemistry of the interaction of HrpY with its target promoter, we purified the wild-type HrpY protein and a nonphosphorylatable D57N mutant version of it. His6-HrpY and His6-HrpY(D57N) were overexpressed using the pET-15b vector. To show that the His6 tag did not affect biological activity, the his6-hrpY gene was subcloned into pRK415. Although this recombinant plasmid had a mild adverse effect on the growth of P. stewartii transconjugants, it complemented a hrpY null mutant for virulence (data not shown). We therefore decided to use the His6-tagged form of the protein for further studies due to the convenience of purification. Induction of the hrpY and hrpY(D57N) genes in plasmids pMM221 and pMM222 in E. coli BL21(DE3/pLysS) resulted in the production of 26-kDa polypeptides, which were not present in uninduced cells. (For His6-HrpY see Fig. S2, lane 2 versus lane 1, in the supplemental material; His6-HrpY[D57N] is not shown). Fig. S2 in the supplemental material shows recovery of His6-HrpY after various steps in its purification by immobilized metal affinity chromatography using step-elution gradients. Highly purified His6-HrpY was recovered from the 136 to 250 mM NaCl fractions after anion exchange chromatography. In all cases, purity was >95%, and background kinase activity was not visible by autoradiography of protein samples incubated with [
-32P]ATP. The molecular weight of the polypeptides was confirmed by Q-TOF ESI MS. For the His6-HrpY sample, the major protein species had a molecular mass of 26,051 ± 58 Da, whereas His6-HrpY(D57N) had a mass of 26,122 ± 76 Da, both in close agreement with the expected mass of 26.1 kDa. Finally, Western blot analysis using anti-His6 monoclonal antibody confirmed the identity of the recombinant polypeptides (not shown).
In vitro binding of HrpY to the hrpS regulatory region.
The binding of HrpY to various DNA fragments spanning the hrpS promoter and regulatory region located between the IS-like element and hrpY was studied by EMSAs. These fragments were synthesized by PCR and end-labeled with 32P. Their map positions are shown in Fig. 4A. In an initial experiment using the 327-bp fragment A (+85 to 241) as a probe, increasing concentrations of unphosphorylated His6-HrpY (
1.2 µM) were incubated with 20 fmol of 32P-labeled fragment A DNA for 40 min, and then the protein-DNA complexes were separated from the free probe by electrophoresis in native 6% acrylamide gels (Fig. 4B). All reactions were performed in a large molar excess of the nonspecific competitor poly(dI-dC). At 1.2 µM, HrpY maximally retarded the mobility of fragment A. When lower concentrations of HrpY were used, complexes of intermediate mobility were observed migrating between the free probe and the retarded probe. The intermediate complexes formed wavy bands and may have been produced upon dissociation of the binding complex at lower HrpY concentrations. This has been reported in other systems (9). Similar results were obtained with the His6-HrpY(D57N) variant (data not shown). In a specificity control, the binding of HrpY to fragment A was dramatically reduced by competition with a 63-fold molar excess of cold fragment A (Fig. 4B). These results demonstrate specific binding of His6-HrpY to the full-length hrpS promoter region.
![]() View larger version (30K): [in a new window] |
FIG. 4. EMSA of the HrpY-PhrpS interaction. (A) Map of the probes used. The hrpS promoter region was amplified by PCR from plasmid pMM58 to produce fragments A, B, C, C1, C2, and C3. Coordinates are relative to the transcription start site, and sizes are reported in base pairs. The fragments shown were used in electrophoretic mobility shift experiments as either radiolabeled probes or cold specific competitors. (B) Binding of HrpY to fragment A and specific competition titration. Increasing concentrations of HrpY (0 to 1.2 µM range) were incubated with 25 fmol of 32P-labeled fragment A. The molar excesses of the unlabeled specific competitor are indicated above the lanes (0x, 8x, 15x, and 63x). The size of the free probe in base pairs is shown. (C) Competition analysis of the binding of HrpY to hrpS fragment C. HrpY was incubated with 32P-labeled DNA fragment C with and without competing unlabeled DNA fragments at various molar excesses (fragment C was used as the unlabeled specific competitor while fragment C3, which does not bind HrpY, was the nonspecific competitor). Unbound probe C in lane 8 does not match the size of unbound probe C in lane 1 due to gel migration distortion.
|
70 promoter, probe C3 (+85 to 15) containing the 5' UTR upstream of the IS-like element, and probe C (+85 to 175) spanning C1, C2, and C3. In each assay, 10 to 15 fmol of probe was incubated with 4.7 µM or 12.5 µM HrpY with or without cold specific competitor DNA. HrpY formed high-affinity complexes with fragment C, similar to what was observed for probe A (Fig. 4C). Fragments B, C1, and C3 were not bound by HrpY, but weak binding was observed to fragment C2 (data not shown). Subsequent footprinting experiments, described below, revealed that HrpY protected a region that was mostly contained in fragment C2 but extended 8 bp into fragment C1. To further demonstrate the specificity of the binding of HrpY to fragment C, excess unlabeled fragment C3 was incubated with HrpY and 32P-labeled probe C (Fig. 4C). Up to 75-fold molar excess of unlabeled fragment C3, acting here as an nonspecific competitor, did not block the binding of HrpY to probe C, whereas binding was increasingly reduced in the control assay using cold fragment C (Fig. 4C). DNase I footprinting of the hrpS regulatory region. The precise HrpY-binding sequences were identified by testing the ability of HrpY to protect against DNase I cleavage of the hrpS promoter. A fragment with the 175 to + 85 region of PhrpS (Fig. 4A, fragment C), which was fluorescently 5' labeled with 6-FAM, was incubated with increasing amounts of His6-HrpY and then treated with DNase I. The digestion patterns were analyzed by capillary electrophoresis using an automated sequencer (Fig. 5). Two regions between 107 and 84 (FP-I) and between 78 and 55 (FP-II) were protected, which was indicated by disappearing nucleotide peaks as the HrpY concentration increased. The bases in FP-I were protected at a lower concentration of protein than FP-II, implying higher binding specificity for that region. These footprinting results further demonstrate that the binding of HrpY to PhrpS described in the gel shift experiments is specific to a precise region of the promoter localized just upstream of the 35 to 10 promoter box. DNase I footprinting did not reveal any binding elsewhere in the PhrpS region (Fig. 5 and data not shown). The two footprinted regions span the direct repeats described above, which are conserved to various degrees in Erwinia spp., and correspond to the region shown by deletion analysis to be essential for HrpY-dependent regulation of hrpS (Fig. 3).
![]() View larger version (38K): [in a new window] |
FIG. 5. DNase I footprinting of the HrpY binding sites. DNase I digestion reactions were prepared and analyzed by capillary electrophoresis in an ABI 3770 sequencer as described in Materials and Methods. The fluorescence intensity of the 6-FAM-labeled fragments is shown on the y axis of each electropherogram, fragment sizes are given along the top in nucleotides as determined by comparison to the internal molecular weight standards (light gray peaks marked by an asterisk in the bottom electropherogram), and the coordinates of the peaks (bases) relative to the transcription start site are given along the bottom. Solid bars at the top (labeled as FP-I and FP-II) indicate PhrpS regions protected by His6-HrpY. Four electropherograms from reactions with decreasing amounts of His6-HrpY are shown: 80 µM (a) 8 µM (b), 2 µM (c), and 0.5 µM (d) HrpY. The bovine serum albumin-only control is also shown (e).
|
To directly test whether or not D57 is the sole phosphorylation site in HrpY, we developed an in vitro system to phosphorylate HrpY. The putative cognate sensor kinase for HrpY is probably HrpX, because it is encoded by the same operon and nonpolar, null mutations in hrpX decrease both hrp gene expression in IM5.5 medium and virulence (25). However, our attempts to purify either full-length or truncated active HrpX for in vitro transphosphorylation assays repeatedly failed (data not shown). Alternatively, we used recombinant S. enterica BarA198 sensor kinase (a truncated version of BarA engineered with an N-terminal his6 tag) for our experiments. In S. enterica, BarA transphosphorylates the SirA response regulator, which belongs to the same class of regulators (FixJ) as HrpY. Figure 6 (lanes 1 and 5) shows that purified HrpY alone did not catalyze an autophosphorylation reaction in the presence of [
-32P]ATP. On the other hand, BarA198 autophosphorylated in presence of [
-32P]ATP (lanes 2 and 6), and BarA198
P efficiently transferred 32Pi to HrpY (lanes 3 and 7). The HrpY/BarA198 complex appeared more active than BarA198 alone in catalyzing the autophosphorylation reaction, at least under the conditions used here. Finally, the HrpY(D57N) mutant protein was not phosphorylated by BarA198 and [
-32P]ATP (lanes 4 and 8), demonstrating that D57 is probably the only phosphorylation site in HrpY efficiently recognized by this kinase. Furthermore, this is consistent with our previous finding that D57A and D57N mutant alleles abolish hrp gene expression and virulence when present in single copy (25).
![]() View larger version (53K): [in a new window] |
FIG. 6. In vitro transphosphorylation of HrpY. Reaction mixtures contained [ -32P]ATP, S. enterica BarA198 sensor kinase, and either HrpY or HrpY(D57N). Reactions were separated by SDS-PAGE and visualized by Coomassie brilliant blue staining (left) or PhosphorImager scanning (right). Negative controls consisted of HrpY and HrpY(D57N) incubated in the presence of [ -32P]ATP without BarA.
|
![]() View larger version (35K): [in a new window] |
FIG. 7. Effect of phosphorylation on the in vitro binding affinity of HrpY to PhrpS DNA. The binding isotherm plot for HrpY is shown. Increasing concentrations of HrpY or HrpY P (from 1 nM to 80 µM), prepared upon incubation with a 2:1 molar ratio of kinase:response regulator for 30 min, were mixed with an average of 40 fmol of 32P-labeled probe DNA at room temperature. Unphosphorylated HrpY samples contained the sensor kinase, but ATP was omitted from the reaction. The positions of the free probes and complexes and their intensities were determined by exposing the dried gel to a phosphor storage screen (inset). The signal was quantified with ImageQuant software. The bound fraction was plotted against protein concentration and fitted to a hyperbolic model using GraphPad Prism.
|
|
|
|---|
An initial objective in our characterization of the hrpS promoter region was to locate the DNA sequences needed for activation by HrpY. Using deletion analysis, we demonstrated that at least two sites in the long 5' hrpS regulatory region are simultaneously required for HrpY-dependent activation of PhrpS. The first of these sites is just a few bases upstream of a
70 promoter box, which is over 600 bp from the ORF. HrpY binds to this region in vitro with two footprints of 24 and 16 bp, which span the two 10-bp DRs (Fig. 6). The second site (contained within fragment B) (Fig. 4) is located farther upstream (175 to 241) and does not bind HrpY (Fig. 4), even when it is phosphorylated (data not shown). Deletion of this second region rendered the hrpS-uidA fusion in pMM396 totally inactive in both wild-type and hrpY backgrounds (Fig. 3). This deletion included a likely IHF binding site at 191 to 179, and precise deletion of this element led to a dramatic decrease in hrpS expression in both genetic backgrounds, which was comparable to that of pMM396 (Fig. 3). To genetically test the notion that upstream binding of IHF and/or other factors may be important for DNA looping and downstream HrpY-dependent expression of hrpS, we altered the DNA helix phase by introducing 5-bp or 10-bp deletions (corresponding to one half or one full helical turn) into a region midway between the IHF consensus element and the HrpY binding site. Consistent with a requirement for DNA looping, both 5-bp deletions reduced hrpS expression to levels comparable to those of hrpY null mutants, whereas the 10-bp deletion spanning the same sites actually increased hrpS expression. At this point, we have no biochemical proof that any factor, other than HrpY, directly binds the hrpS promoter region, but our preliminary finding that crude extracts from hrpY null mutants still retard fragment A in gel shift experiments (M. Merighi and D. Coplin, unpublished data) is consistent with this hypothesis.
As mentioned above, the region proximal to the hrpS promoter, which was extensively characterized by deletion analysis, EMSA, and DNase I footprinting, includes two 10-bp DRs (AAATCCTTAC-N11-AATTCCTTAC; consensus, AAWCCTTAC). These are conserved in P. agglomerans pv. gypsophilae, E. amylovora, E. carotovora subsp. atroseptica, and E. chrysanthemi (data not shown). Similar A+T-rich binding sites have been found for other FixJ class regulators, e.g., RAAAYY for E. coli UhpA (9) and TACYNMT for E. coli NarL (34). Complex binding patterns at multiple sites have likewise been observed for NarL and UhpA and also for E. coli OmpR, a "winged helix" class regulator. NarL dimers (21) bind, in a cooperative and hierarchical manner, to four heptamers located in front of the fndG operon and to eight heptamers in front of the narG operon, (20). UhpA binds as a dimer to inverted repeats in the uhpT promoter, which were mapped by iron chelated hydroxy-radical footprinting (28). On the other hand, asymmetrical OmpR dimers bind, in a cooperative fashion, to multiple 10-bp sites arranged in tandem (13). At this point, we do not know whether HrpY binds as a dimer or as an oligomeric complex. The relatively large footprinted region that we found suggests that the latter may occur. Interestingly, the distal footprint (FP-I) seems to show an apparently higher affinity for HrpY than the proximal footprint (FP-II), so that activating site occupancy may differ at various levels of HrpY phosphorylation in vivo. A simplified working model for hrpS regulation therefore involves HrpY binding at the proximal site, possibly in two different steps, and then acting cooperatively with an unidentified coactivator(s) that binds at the distal site (175 to 241; fragment B). The DNA-bending introduced by IHF would then facilitate the interaction of this coactivator with HrpY. This would explain why loss of the IHF site in pDM2958 did not have as dramatic effect on the basal level of PhrpS expression in the hrpY background (24% to 19%) as did deletion of fragment B in pMM396 (24% to 0.7%). The restoration of the basal level by further deletion of the region from 175 to 100 in pMM393 could mean that a corepressor could bind between HrpY and the putative coactivator.
Another objective of this study was to explore the role of phosphorylation in modulating the activity of HrpY as a DNA-binding protein. Computer modeling predicted that D57 is the most likely phosphorylation site in HrpY (22). The function of this site was initially tested using hrpY alleles with conservative or neutral substitutions at residue D57. We observed the ability of hrpY(D57A) or hrpY(D57N) to complement hrpY null mutants for virulence when ectopically expressed from plasmids (25). On the other hand, substitutions at D57 abolished virulence when expressed in single copy from the chromosome. Such copy number effects are not uncommon for response regulators of this class (9). One frequent explanation is that phosphorylation enhances binding to the target promoters, but, at high concentrations, the unphosphorylated response regulator may still bind to and form active complexes on the target DNA. Another common hypothesis is that increased expression of the response regulator may lead to cross talk with other sensor kinases. The first explanation seems more likely for HrpY. Indeed, expression of an hrpS::lacZ fusion was only partially stimulated by the hrpY(D57N) and hrpY(D57A) alleles when they were ectopically expressed (data not shown). In protein phosphorylation experiments using the heterologous mutant kinase BarA198 (Fig. 7), the HrpY(D57N) protein was not phosphorylated, which provided further evidence that D57 is the sole phosphorylation site. Finally, our in vitro EMSA experiments showed that phosphorylation increased the affinity of HrpY for the hrpS promoter by severalfold. The reduction in hrpS activation by the hrpY(D57N) and hrpY(D57A) alleles, therefore, could simply be due to their decreased ability to bind at the hrpS promoter to the same extent as HrpY
P. Since we found that the proximal binding site, FP-II, had a lower affinity for HrpY, we speculate that, at normal concentrations of HrpY, it may only be occupied when HrpY is completely phosphorylated and that binding to it may be important for full contact and activation of the RNA polymerase holoenzyme at the weak
70 promoter.
Although HrpY needs to be phosphorylated in order to activate PhrpS at normal physiological levels, the HrpX sensor kinase does not appear to be absolutely required for hrp gene expression (25); so we proposed above that an alternate sensor kinase or small phosphodonors may phosphorylate HrpY during infection. HrpX was purified as a recombinant protein, but it did not show kinase activity under the conditions tested (22). Usually, there is a certain degree of specificity between response regulators and their cognate kinases in order to achieve proper regulation (14), but cross talk is a known phenomenon. It is therefore interesting that we were able to use a truncated, mutant form of the S. enterica BarA sensor kinase for this purpose, since this enzyme is reportedly quite specific for its cognate regulator (29). BarA/SirA orthologs, such as GacA/GacS, are found in many
-proteobacteria, including the genera Pseudomonas, Pantoea, and Erwinia. Moreover, these regulators have important roles in regulating the virulence of salmonellae, erwinias, and pseudomonads. A recent BLAST search of the P. stewartii draft genome sequence (http://www.hgsc.bcm.tmc.edu/projects/microbial/Pstewartii/) confirmed the presence of a barA/gacS ortholog. Consequently, we are currently investigating the possibility that this ortholog may function as an alternate kinase in place of HrpX under certain environmental conditions.
Purified S. enterica BarA198 protein was a gift from Max Teplitski and Brian Ahmer.
Supplemental material for this article may be found at http://jb.asm.org/. ![]()
Present address: Department of Microbiology and Molecular Genetics, Harvard Medical School, 200 Longwood Avenue, Boston, MA 02115. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»